🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2002)
All (2002)
Buys (178)
Sells (1824)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
21,577
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
22,344
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
22,694
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
22,983
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
23,198
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Garg Pushkal
— EVP Chief R&D
Mar 4, 2026
Sale
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
23,300
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
QUEST DIAGNOSTICS INC
(DGX)
KUPPUSAMY KARTHIK
— SVP, Clinical Solutions
Mar 4, 2026
Sale
Shares
2,628
Price
$204.86
Total Value
$538.37K
Shares Held After
13,441
% of Holdings
16.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Ellis Andrea
— Director
Mar 4, 2026
Sale
Shares
64,921
Price
$64.87
Total Value
$4.21M
Shares Held After
18,589
% of Holdings
77.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERACYTE, INC.
(VCYT)
Chambers Rebecca
— Chief Financial Officer
Mar 4, 2026
Sale
Shares
13,941
Price
$36.33
Total Value
$506.46K
Shares Held After
131,196
% of Holdings
9.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERACYTE, INC.
(VCYT)
Chambers Rebecca
— Chief Financial Officer
Mar 4, 2026
Sale
Shares
4,400
Price
$35.55
Total Value
$156.41K
Shares Held After
145,137
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Francis Richard D
— President and CEO
Mar 4, 2026
Sale
Shares
23,393
Price
$32.46
Total Value
$759.44K
Shares Held After
1,148,212
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
265
Price
$325.67
Total Value
$86.30K
Shares Held After
95,695
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
345
Price
$324.88
Total Value
$112.08K
Shares Held After
95,960
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
973
Price
$323.84
Total Value
$315.10K
Shares Held After
96,305
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
444
Price
$323.01
Total Value
$143.42K
Shares Held After
97,278
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
368
Price
$321.82
Total Value
$118.43K
Shares Held After
97,722
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
274
Price
$320.81
Total Value
$87.90K
Shares Held After
98,090
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
129
Price
$320.01
Total Value
$41.28K
Shares Held After
98,364
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Greenstreet Yvonne
— Director
Mar 4, 2026
Sale
Shares
135
Price
$319.03
Total Value
$43.07K
Shares Held After
98,493
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TransMedics Group, Inc.
(TMDX)
Lovell Stephanie
— Director
Mar 4, 2026
Sale
Shares
1,193
Price
$149.62
Total Value
$178.50K
Shares Held After
2,866
% of Holdings
29.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Hughes Eric A
— See "Remarks"
Mar 4, 2026
Sale
Shares
11,277
Price
$32.46
Total Value
$366.10K
Shares Held After
97,590
% of Holdings
10.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Schrödinger, Inc.
(SDGR)
Abel Robert Lorne
— EVP, Chief Scientific Officer, Platform
Mar 4, 2026
Sale
Shares
1,300
Price
$12.81
Total Value
$16.65K
Shares Held After
55,897
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TEVA PHARMACEUTICAL INDUSTRIES LTD
(TEVA)
Fox Christine
— EVP, U.S. Commercial
Mar 4, 2026
Sale
Shares
9,098
Price
$32.46
Total Value
$295.36K
Shares Held After
75,010
% of Holdings
10.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Orthofix Medical Inc.
(OFIX)
Cedron Jorge Andres
— CLO
Mar 4, 2026
Sale
Shares
1,405
Price
$12.92
Total Value
$18.15K
Shares Held After
64,119
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
34,297
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
34,505
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
34,777
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
35,544
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
35,894
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
36,183
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Abi-Saab Walid
— Chief Medical Officer
Mar 4, 2026
Sale
Shares
808
Price
$9.06
Total Value
$7.32K
Shares Held After
189,669
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
36,398
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ALNYLAM PHARMACEUTICALS, INC.
(ALNY)
Tanguler Tolga
— EVP, Chief Commercial Officer
Mar 4, 2026
Sale
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
36,500
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CORCEPT THERAPEUTICS INC
(CORT)
Guyer William
— Chief Development Officer
Mar 4, 2026
Sale
Shares
8,233
Price
$35.99
Total Value
$296.35K
Shares Held After
2,231
% of Holdings
78.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Baroldi Joseph
— EVP, Chief Business Officer
Mar 4, 2026
Sale
Shares
201
Price
$80.00
Total Value
$16.08K
Shares Held After
4,347
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Baroldi Joseph
— EVP, Chief Business Officer
Mar 4, 2026
Sale
Shares
238
Price
$80.00
Total Value
$19.04K
Shares Held After
4,347
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
LOSCALZO JOSEPH
— Director
Mar 4, 2026
Sale
Shares
200
Price
$80.00
Total Value
$16.00K
Shares Held After
36,330
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Brosius Mark
— SVP & Chief Mfg and Supply Cha
Mar 4, 2026
Sale
Shares
2,362
Price
$498.68
Total Value
$1.18M
Shares Held After
3,554
% of Holdings
39.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Monte Rosa Therapeutics, Inc.
(GLUE)
Dunn Edmund
— Principal Accounting Officer
Mar 4, 2026
Sale
Shares
139
Price
$17.96
Total Value
$2.50K
Shares Held After
22,554
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NovoCure Limited
(NVCR)
Paravasthu Mukund
— Chief Operating Officer
Mar 4, 2026
Sale
Shares
5,377
Price
$13.31
Total Value
$71.54K
Shares Held After
116,078
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nautilus Biotechnology, Inc.
(NAUT)
Patel Sujal M
— Director
Mar 4, 2026
Purchase
Shares
25,000
Price
$2.61
Total Value
$65.24K
Shares Held After
10,366,721
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BrightSpring Health Services, Inc.
(BTSG)
Phipps Jennifer A
— Chief Financial Officer
Mar 4, 2026
Sale
Shares
35,000
Price
$41.15
Total Value
$1.44M
Shares Held After
196,840
% of Holdings
15.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Apogee Therapeutics, Inc.
(APGE)
Dambkowski Carl
— Chief Medical Officer
Mar 4, 2026
Sale
Shares
200
Price
$73.26
Total Value
$14.65K
Shares Held After
209,773
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BrightSpring Health Services, Inc.
(BTSG)
ROUSSEAU JON B
— Director
Mar 4, 2026
Sale
Shares
220,000
Price
$41.15
Total Value
$9.05M
Shares Held After
1,023,880
% of Holdings
17.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Apogee Therapeutics, Inc.
(APGE)
Dambkowski Carl
— Chief Medical Officer
Mar 4, 2026
Sale
Shares
2,075
Price
$71.98
Total Value
$149.36K
Shares Held After
209,973
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Apogee Therapeutics, Inc.
(APGE)
Dambkowski Carl
— Chief Medical Officer
Mar 4, 2026
Sale
Shares
3,225
Price
$70.33
Total Value
$226.81K
Shares Held After
212,048
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BrightSpring Health Services, Inc.
(BTSG)
Nalley Lisa A
— Title: Chief of Staff and Senior Vice President, Human Resources
Mar 4, 2026
Sale
Shares
30,000
Price
$41.15
Total Value
$1.23M
Shares Held After
110,594
% of Holdings
21.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Mazumdar Claire
— Director
Mar 4, 2026
Sale
Shares
2,631
Price
$18.73
Total Value
$49.29K
Shares Held After
339,392
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
Espinoza Octavio
— Chief Financial Officer
Mar 4, 2026
Sale
Shares
3,413
Price
$208.80
Total Value
$712.62K
Shares Held After
21,662
% of Holdings
13.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
Espinoza Octavio
— Chief Financial Officer
Mar 4, 2026
Sale
Shares
2,457
Price
$207.91
Total Value
$510.82K
Shares Held After
25,075
% of Holdings
8.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1301–1350 of 2002 transactions (page 27 of 41)
Version: v26.3.33